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Mutations were introduced into mouse adenovirus type 1 (MAV-1) early region 3 (E3) initiator codons by homologous
recombination between viral DNA and a plasmid containing a mutagenized E3 region. The resulting mutant virus, pmE312,
contained ATG3 TTA mutations at codon positions 1 and 4 and was expected to be null for the expression of the E3 proteins.
However, gp11K, an MAV-1 E3 glycoprotein of 14K molecular weight, was detected in mutant-infected cell lysates at levels
about 10–12% of that of wild-type (wt) virus at late times in infection. The gp11K polypeptide produced by pmE312 at late times
was immunoprecipitated with two E3-specific antisera prepared against different regions of the protein. Like gp11K produced
by wt virus infections, it was sensitive to endoglycosidase H (endo H) and thus resident in the endoplasmic reticulum (ER).
In pmE312-infected cells treated with cytosine arabinoside (araC), an inhibitor of DNA replication, the gp11K protein was not
detected by immunoprecipitation. This indicates that gp11K expression in pmE312-infected cells at late times was dependent
on DNA replication and that it was thus translated from a late transcript. In vitro translation of poly(A)1 RNA from mock-,
wild-type-, and pmE312-infected cells showed that gp11K was translated from late mRNA as an ;28K fusion between a late
protein and gp11K. Our data are consistent with a model in which gp11K is expressed at late times as a late protein–gp11K
chimera in both wt- and mutant-infected cells. This chimera is then processed: removal of a large N-terminal sequence
results in the observed 14K ER-localized gp11K. © 1999 Academic Press
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Mouse adenovirus type 1 (MAV-1) has a double-
tranded, linear, DNA genome that is 30,944 base pairs
n length (Meissner et al., 1997). The genomic organiza-
ion of MAV-1 is quite similar to that of human adenovi-
uses (hAds). Early region 1 (E1) is encoded on the top
trand of the virus near the left end. The late genes fill the
ight two-thirds of the top strand of the virus, with the
arly region 3 (E3) located between the late region 4 (L4)
nd the late region 5 (L5) genes. Early region 4 (E4), early
egion 2 (E2), and IVa2 map to the bottom strand of the
enome. The arrangement of MAV-1 genes is more com-
act than that of hAds, and unlike hAds, the MAV-1
enome does not encode virus-associated (VA) RNAs
Meissner et al., 1997).
E3 of hAd2/5 has been studied extensively. Although
ot essential for viral replication in vitro, E3 encodes
everal proteins involved in modulation of the immune
esponse. The hAd E3 gp19K protein sequesters major
istocompatibility complex class 1 antigens (MHC) in the
1 Current address: Southeast Poultry Research Laboratory, Agricul-
ural Research Service, U.S. Department of Agriculture, Athens, GA
0605.
2 To whom correspondence and reprint requests should be ad-
ressed at Department of Genetics, University of Georgia, Life Sci-
nces Building, Athens, GA 30602-7223. Fax: (706) 542-3910. E-mail:ipindler@arches.uga.edu.
119ndoplasmic reticulum (ER) and prevents their expres-
ion on the surface of the infected cells (Andersson et al.,
985; Burgert and Kvist, 1985; Flomenberg et al., 1992).
hree proteins encoded in the E3 region (10.4K/14.5K,
lso known as RIDa/RID-b, respectively; and 14.7K) are
nvolved in protecting infected cells from tumor necrosis
actor (TNF)-induced apoptosis (Dimitrov et al., 1997;
ooding et al., 1988, 1990, 1991; Horton et al., 1991;
rajcsi et al., 1996). RID-a/RID-b also protect against
as-induced apoptosis (Shisler et al., 1997; Tollefson et
l., 1998). The adenovirus death protein (ADP) also maps
o this region and is important for release of virus in cell
ulture at late times in infection (Tollefson et al., 1996a,b).
here are other proteins encoded by E3 whose functions
re unknown. Since the known functions of hAd E3
roteins are largely involved in counteracting the im-
une response, it follows that they are important in
nfections in vivo. Early genes have been shown to be
mportant for hAd infections of cotton rats and mice
Ginsberg et al., 1989, 1990, 1991). Infections with hAd E3
eletion mutant viruses in cotton rats and mice are
ssociated with an increase in inflammation relative to
nfections by wild-type (wt) virus (Ginsberg et al., 1989,
990, 1991; Sparer et al., 1996), suggesting that the E3
enes suppress the ability of the immune system to
ecognize and clear the hAd infection in these animal
odels. This may be one factor enabling hAds to persistn humans, their natural host.
0042-6822/99 $30.00
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120 CAUTHEN AND SPINDLERE3 is quite divergent even among the hAds. Thus it is
ot surprising that the level of similarity is low between
he proteins encoded by hAd E3 genes and those of
AV-1 (Bailey and Mautner, 1994). In fact, there are no
roteins in the databases that have significant homology
o the putative MAV-1 E3 proteins. The E3 region of
AV-1 synthesizes three mRNAs from a nearby early
romoter. These transcripts are 59 and 39 coterminal and
ach contains three exons and two introns (Fig. 1). The
irst introns of E3 mRNAs use the same donor and
cceptor splice sites such that when the mRNAs are
ranslated, the putative proteins share the same N-ter-
inal sequence. Due to differential use of donor and
cceptor splice sites of the second intron, each putative
rotein encodes a unique C-terminus (Beard et al., 1990).
he three proteins are designated gp11K (class 1), class
, and class 3. Only gp11K has been detected in a wt
nfection (Beard and Spindler, 1995). gp11K encodes an
-terminal signal sequence that is cleaved upon entry
nto the ER. gp11K is N-glycosylated, and it resides in the
R as a peripheral membrane protein (Beard and Spind-
er, 1995). No specific function has been attributed to any
f the MAV-1 E3 proteins to date, but they are important
or the pathogenesis of the virus in mice (Beard and
pindler, 1996).
Due to the importance of E3 in the pathogenesis of
Ads (Ginsberg et al., 1989, 1990, 1991) and MAV-1
Beard and Spindler, 1996), we were interested in assay-
ng the pathogenicity of an E3 null virus. At the onset of
his study, no mutant virus existed that was null for the
xpression of all the MAV-1 E3 proteins. Beard and Spin-
ler (1996) had constructed a virus, pmE310, that had the
nitiator codons of the E3 region mutated from ATG to
TG. This mutant was examined at late times postinfec-
ion and found to synthesize low levels of gp11K (about
8% of wt levels; Beard and Spindler, unpublished obser-
ations). Because there were reports in the literature of
ranslation initiation in eukaryotes from a TTG codon
Guss et al., 1986; Zemmour et al., 1992), it was hypoth-
sized that the gp11K detected in pmE310-infected cell
ysates was due to leaky translation initiation from the
TG (Beard and Spindler, 1996). There were no reports of
ranslation from a TTA codon in eukaryotes in the litera-
ure, so we designed and constructed pmE312 as de-
cribed here. We expected this mutant virus to be unable
o synthesize gp11K or the other E3 proteins. Surpris-
ngly, we found that gp11K was expressed at late times in
ells infected by this mutant at levels about 10–12% of
hat produced in wt-infected cells. Our data are consis-
ent with late gp11K expression in both wt and pmE312
nfections occurring as a fusion between a late viral
olypeptide and gp11K, translated from an alternatively
pliced late mRNA. The late protein sequences of the
usion protein may be those of pVIII, whose gene is
mmediately upstream of E3. We hypothesize that the fusion protein is processed to its mature size of 14K and
ocalized to the ER using the gp11K signal sequence.
RESULTS
Construction of a MAV-1 E3 initiator methionine mu-
ant. The MAV-1 E3 region synthesizes three mRNA spe-
ies at early times in infection from a nearby promoter
Beard et al., 1990). These RNAs overlap and share a
ommon N-terminus when translated, but produce
nique C-termini by differential use of donor and accep-
or splice sites (Fig. 1). Because the E3 mRNAs overlap
ith and are translated in the same frame as the pVIII
oding region and are very closely flanked by the fiber
ene (Fig. 1), it was not possible to delete the E3 region
o create a mutant null for the expression of the E3
roteins. To produce a potential E3 null mutant, we mu-
ated the two putative initiator codons at positions 1 and
from ATG to TTA. Conservative amino acid changes
rom methionine to leucine at these positions in the pVIII
oding region were shown previously to produce viable
irus, pmE310 (Beard and Spindler, 1996). To ensure that
o other methionines could be used as start sites for
ranslation, the other two methionine codons in the E3
oding region were also mutated. The mutations were
enerated first in a plasmid encoding the E3 region by
ligonucleotide site-directed mutagenesis. The mutated
3 region was then transferred from the plasmid to viral
NA by homologous recombination in IE3.3 cells as
reviously described (Beard and Spindler, 1996). Se-
uence analysis confirmed that the expected mutations
ere incorporated into each viral isolate. Upon growing
his virus in 3T6 cells, we noted that pmE312 and other
ndependent isolates (pmE311 and pmE313) grew to ap-
roximately one log lower titers than wt virus, had
lightly smaller plaques, and exhibited a unique cyto-
athic effect (CPE) (data not shown).
The 50% lethal dose (LD50) for pmE312 was determined
o be 102.9 PFU in NIH Swiss outbred mice. This LD50
alue was approximately 4 log units higher than that of
t virus, which averages 1021.2 PFU (Beard and Spindler,
996; Kring et al., 1995; Smith et al., 1998; MAV-1 has a
article to PFU ratio of 1000:1 in 3T6 cells), indicating that
mE312 was less virulent in mice than wt virus. However,
mE312 was slightly less virulent than pmE310 (LD50s of
02.9 and 101.5 PFU, respectively), which may correlate
ith greater amounts of gp11K synthesized by pmE310.
NA was isolated from spleens of pmE312-infected
ice. The E3 region was amplified by PCR with viral-
pecific primers and sequenced. The E3 mutations were
resent as expected in all samples tested (data not
hown).
Protein expression in pmE312-infected 3T6 cells. To
etermine whether pmE312 expressed the E3 proteins,
e immunoprecipitated [35S]cysteine-labeled proteinsrom mock-, wt-, and pmE312-infected cell lysates (Fig. 2).
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121LATE EXPRESSION OF MAV-1 gp11Khe E3 proteins were immunoprecipitated as previously
escribed (Beard and Spindler, 1995) using an antiserum
enerated against an epitope unique to gp11K (a-E3-1).
FIG. 1. MAV-1 genome and mRNA structure for pVIII, E3, fiber, and puta
nits (m.u.) using the numbering scheme for the MAV-1 HindIII-C fragment
f the genome encodes pVIII, E3, and fiber. The E3 and pVIII coding regions
ithin the first intron of E3, though the pVIII mRNA extends to the end of the
nd coding regions are shown as boxes. E3 mRNA splice junctions are
leavage site is indicated, falling after amino acid 35 (nt 1146). Differential
re not drawn to scale; they are 28, 10, and 100 amino acids for gp11K, cl
p11K, class 2, and class 3 proteins terminate at nts 1449, 1435, and 1725, re
hat we predict occurs by splicing of the pVIII mRNA at the usual E3/gp11K s
nd right (MAVR1445) end primers used in RT-PCR experiments, which pr
FIG. 2. Immunoprecipitation and endo H treatment of [35S]cystein
mmunoprecipitated with a-E3-1 antiserum and then either treated (1
lectrophoresed on a 10–18% gradient polyacrylamide SDS gel, and p
uninfected) cell lysates; lanes 3–7, wt-infected cell lysates; lanes 8–11,
he bracket on the right indicates the size of gp11K products treated a
ndo H-treated; (2), mock-endo H-treated; E, early (20 h p.i.); L, late (40 h p.ihen mock-infected cell lysates were immunoprecipi-
ated with a-E3-1, no E3 proteins were detected, as
xpected (Fig. 2, lane 2). E3 proteins were also not
II–gp11K. This diagram represents the MAV-1 genome from 77 to 89 map
ion No. M30594) (Beard et al., 1990; Raviprakash et al., 1989). This portion
and are translated in the same frame. The pVIII coding region terminates
ion. Introns are denoted by carets. mRNA is denoted by lines with arrows,
ted by the nucleotide numbers below the mRNA. The signal sequence
of boxes indicates different proteins. The unique portions of the proteins
nd class 3 proteins, respectively. The E3 proteins start at nt 890, and the
ely. The lower portion of this diagram shows a putative pVIII–gp11K fusion
tes (see text). Arrowheads below the fusion mRNA indicate left (MAVR444)
products consistent with this splicing pattern (see text).
ed mock-, wt-, and pmE312-infected cell lysates. E3 proteins were
H) or mock-treated (2 endo H) with endo H. Samples were then
bands were visualized with a phosphorimager. Lanes 1 and 2, mock
-infected cells. The marker lane is on the left with protein sizes noted.
k-treated with endo H. PI, preimmune serum; I, a-E3-1 antiserum; (1),tive pVI
(Access
overlap
E3 reg
indica
shading
ass 2, a
spectiv
plice sie-label
endo
rotein
pmE312
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122 CAUTHEN AND SPINDLERetected in mock- or wt-infected cell lysates immunopre-
ipitated with preimmune serum (Fig. 2, lanes 1 and 3).
s previously described for wt-infected cell lysates,
p11K (but not class 2 or 3 E3 proteins) was immuno-
recipitated at both early [20 h postinfection (p.i.)] and
ate (40 h p.i.) times after infection using a-E3-1 anti-
erum (Fig. 2, lanes 4 and 6) (Beard and Spindler, 1996).
n pmE312 early-infected cell lysates immunoprecipi-
ated with a-E3-1, no detectable levels of gp11K were
een (Fig. 2, lane 8). However, at late times in infection,
gp11K-size band was immunoprecipitated from
mE312-infected cell lysates (Fig. 2, lane 10). Similar
esults were obtained for wt- and pmE312-infected cell
ysates using a-Eall3 antiserum, which recognizes
pitopes common to all three E3 proteins (Beard and
pindler, 1996) (data not shown). The amount of gp11K
ynthesized by pmE312 at late times was quantitated
sing a phosphorimager and found to be 10–12% of wt
p11K levels. The band migrating below the gp11K band
t approximately 11K in Fig. 2, lanes 4, 6, and 10, is
elieved to be unglycosylated gp11K.
Although a function has not been identified for gp11K,
eard and Spindler (1995) showed that gp11K is local-
zed to the ER. To confirm that the gp11K-sized band
mmunoprecipitated from pmE312-infected cell lysates
y both a-Eall3 and a-E3-1 was gp11K, we immunopre-
ipitated wt- and pmE312-infected cell lysates with
-E3-1 antiserum, followed by treatment or mock-treat-
ent with endoglycosidase H (endo H) as previously
escribed (Beard and Spindler, 1995) (Fig. 2). Endo H
leaves high mannose and hybrid oligosaccharides from
-linked glycosylated proteins. Such oligosaccharides
re indicative of proteins that reside in the ER; therefore,
ndo H sensitivity indicates that a protein is a resident of
he ER. gp11K migrates at approximately 14K on a 10–
8% gradient polyacrylamide SDS gel when mock-
reated with endo H or at approximately 11K when
reated with endo H. In endo H-treated wt-infected cell
ysates (Fig. 2, lanes 5 and 7), the 14K band was no
onger evident and a band of 11K was apparent. This
esult indicates that the N-linked-glycosylation on gp11K
as been cleaved by endo H and that gp11K resides in
he ER as previously shown (Beard and Spindler, 1995).
imilarly, an 11K band was seen in endo H-treated sam-
les from pmE312-infected cell lysates at late times in
nfection (Fig. 2, lane 11). This result confirms that the
p11K-sized band detected at late times in pmE312-
nfected cells is endo H sensitive and is localized to the
R, as in a wt infection.
gp11K synthesis at late times in pmE312-infected cells
s dependent on DNA replication. The major late pro-
oter (MLP) of hAds drives the expression of the late
enes and is dependent on replication of the adenovirus
enome for function. The E3 region of hAds is embedded
ithin the late genes and Tollefson et al. (1992) havehown that hAd E3 proteins can be synthesized from a wate transcript driven by the MLP. The genomic organi-
ation of MAV-1 is conserved with that of hAds, and
AV-1 has a functional MLP (Song et al., 1996; Song and
oung, 1997). Cytosine arabinoside (araC) inhibits ad-
noviral DNA replication (Gaynor et al., 1982) and thus
revents late gene synthesis from the MLP. Immunopre-
ipitation experiments in Fig. 2 showed that gp11K was
ynthesized in pmE312-infected cells at late but not at
arly times in infection. Therefore, we used araC to
nhibit the DNA replication of MAV-1 to determine
hether gp11K was synthesized from a late transcript.
ells were mock-, wt-, or pmE312-infected and mock-
reated or araC-treated, and cell lysates were then im-
unoprecipitated with a-E3-1 antiserum. gp11K and E1A
ere not immunoprecipitated from mock-infected cells,
or were any MAV-1 proteins immunoprecipitated from
t-infected cells with preimmune serum (Fig. 3, lanes 1,
, and 3, respectively). In wt-infected cell lysates, gp11K
as immunoprecipitated at both early and late times and
n the presence and in the absence of araC as expected
Fig. 3, lanes 4, 6, and 9). As seen in Fig. 2, gp11K was
mmunoprecipitated at late but not early times in
mE312-infected cells (Fig. 3, lanes 17 and 12, respec-
ively). However, in the presence of araC, no gp11K was
etected (Fig. 3, lane 14). As controls for MAV-1 early and
ate gene expression and the effects of araC treatment,
e immunoprecipitated aliquots of the same lysates with
-E1A and a-MAV-1 (a-virion) antisera. E1A was immu-
oprecipitated at comparable levels from wt- and
mE312-infected cell lysates at early and late times in
he presence and in the absence of araC [Fig. 3, lanes 5,
, and 10 (wt) and lanes 13, 15, and 18 (pmE312)]. This
ndicates that early gene synthesis was not impaired in
mE312-infected cells or by araC treatment. Virion pro-
eins were detected at late times in the absence but not
n the presence of araC in both wt- and pmE312-infected
ell lysates [Fig. 3, lanes 11 and 8 (wt) and lanes 19 and
6 (pmE312)]. This result confirms that late gene synthe-
is was effectively inhibited by araC in both wt- and
mE312-infected cell lysates. We conclude that synthesis
f gp11K at late times in pmE312-infected cells is depen-
ent on DNA replication and therefore that gp11K is
ranslated from a late transcript in pmE312-infected cells.
gp11K is translated at late times in both wt and
mE312 infections as a fusion with a late protein. The
esults in Figs. 2 and 3 showing that gp11K was trans-
ated in pmE312-infected cells were surprising since the
nitiator codons of the E3 proteins had been mutated. It
as of interest to determine how translation of gp11K
as initiated. Since the MAV-1 E3 region is embedded in
he late genes, it was possible that gp11K was synthe-
ized from a late mRNA that, when translated, encoded a
usion between a late protein and gp11K. We performed
he following experiment to determine whether gp11K
ould be translated from a late viral transcript as a fusion
ith a late protein. Total RNA was isolated from mock-,
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123LATE EXPRESSION OF MAV-1 gp11Kt-, and pmE312-infected cells harvested at early and
ate times postinfection in the presence or in the ab-
ence of araC. Poly(A)1 RNA was isolated from these
amples and translated in vitro with or without canine
ancreatic microsomal membranes (CPMM) in the pres-
nce of [35S]cysteine. Each sample was immunoprecipi-
ated with a-E3-1 antiserum and analyzed by electro-
horesis and phosphorimagery. Figure 4 (lanes 1 and 2)
hows that gp11K was not immunoprecipitated from in
itro translated RNA harvested from mock-infected cells
n the presence or in the absence of CPMM. Translation
f RNA harvested at early times (20 h p.i.) from wt-
nfected cells yielded a protein band of approximately
4K in the absence of CPMM, consistent with the size of
p11K plus its signal sequence (Fig. 4, lane 3) (Beard and
pindler, 1995). When CPMM were added to this in vitro
ranslation reaction, a slightly higher molecular weight
and was seen, consistent with cleavage of the signal
equence and addition of an N-linked-glycosylation (Fig.
, lane 4) (Beard and Spindler, 1995). In wt-infected cells
t late times (40 h p.i.) after infection in the presence or
n the absence of araC, bands of approximately 14K were
mmunoprecipitated from RNA translated in vitro in the
bsence and in the presence of CPMM (Fig. 4, lanes
–8). These bands were the same size as the bands
een in the early (20 h p.i.) samples (Fig. 4, lanes 3 and
). Notably, translation of wt-infected late RNA in the
FIG. 3. Immunoprecipitation of [35S]cysteine-labeled proteins from ly
raC. Cells were infected in the presence or in the absence of a
mmunoprecipitated with a-E3-1 antiserum in lanes 1, 4, 6, 9, 12, 14, and
, 5, 7, 10, 13, 15, and 18. Virion proteins were immunoprecipitated with A
ith preimmune serum. After immunoprecipitation, samples were elect
ere visualized with a phosphorimager. Marker protein sizes in kilodalt
roteins are noted on the right.bsence of CPMM yielded a band of approximately 28K tFig. 4, lane 5). This 28K band was present although less
ntense in the presence of CPMM (Fig. 4, lane 6), sug-
esting that some of it may have been processed to the
4K-sized gp11K. In the presence of araC, this 28K band
as not immunoprecipitated from in vitro translated RNA
arvested from wt-infected cells (Fig. 4, lanes 7 and 8),
ndicating that production of the 28K band was sensitive
o araC and that the band was likely translated from a
FIG. 4. Immunoprecipitation of [35S]-cysteine-labeled proteins from in
itro translations of poly(A)1 RNA from mock-, wt-, and pmE312-infected
ells. RNAs were harvested at time points indicated. In vitro translation
eactions were carried out in the presence (1) or in the absence (2) of
PMM as indicated. Proteins were immunoprecipitated with a-E3-1
ntiserum, electrophoresed on a 10–18% gradient polyacrylamide SDS
el, and visualized by phosphorimager. Marker protein sizes in kilodal-
f mock-, wt-, and pmE312-infected cells, treated or mock-treated with
nd harvested at 20 and 40 h p.i. as indicated. E3 proteins were
proteins were immunoprecipitated with AKO 7-147 antiserum in lanes
8 antiserum in lanes 8, 11, 16, and 19. Lane 3 was immunoprecipitated
sed on a 10–18% gradient polyacrylamide SDS gel, and protein bands
noted on the left, and the position of gp11K (E3), E1A, and late (virion)sates o
raC a
17. E1A
KO 1-6
rophore
ons areons are noted to the left.
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124 CAUTHEN AND SPINDLERate transcript. In vitro translated RNA harvested at 20
nd 40 h p.i. from pmE312-infected cells yielded a 28K
and in the absence of CPMM (Fig. 4, lanes 9 and 11).
his 28K band was not detected (Fig. 4, lane 10) or was
ess intense (Fig. 4, lane 12) in the presence of CPMM,
nd a 14K band was seen, suggesting that the 28K band
as processed to the mature, 14K-sized gp11K. No 14K-
ized gp11K band was detected from early pmE312-
nfected RNAs translated in vitro in the absence of
PMM (lane 9), consistent with results in Figs. 2 and 3.
he appearance of the faint 28K and 14K bands at 20 h
.i. in pmE312-infected samples (lanes 9 and 10) is likely
ue to the onset of some late mRNA synthesis at 20 h p.i.
n this experiment. In the presence of araC at 40 h p.i. in
mE312-infected cells, no 28K or 14K protein bands were
mmunoprecipitated from in vitro translated RNA in the
resence or in the absence of CPMM (Fig. 4, lanes 13
nd 14). This result indicates that the 28K and 14K protein
ands were dependent on DNA replication for their syn-
hesis and thus were translated from late transcripts.
hese data also show that gp11K is translated from a late
RNA in both wt- and pmE312-infected cells as a 28K
usion between a late protein and gp11K. We hypothesize
hat the mature, 14K, ER-localized gp11K protein is pro-
uced by cleavage of the fusion protein at the gp11K
ignal sequence cleavage site. Although this would
ean removal of a large N-terminal “leader” amino acid
equence, such events are not unprecedented. An N-
erminus of approximately 110 or 200 amino acids can be
rocessed in in vitro translation reactions or in Xenopus
aevis oocytes (Perara and Lingappa, 1985; Simon et al.,
987). The relative amounts of the 28K and 14K bands in
ane 5 were determined by phosphorimagery to be 24
nd 76% of the total gp11K-specific material. This indi-
ates that 24% of the a-gp11K precipitable protein in the
n vitro translation of wt-infected cell RNAs is synthe-
ized as a fusion protein.
Identification of an in vivo RNA capable of encoding a
VIII–gp11K fusion. Sequence analysis of polyadenyla-
ion signals for the MAV-1 L4 mRNAs (encoding 100K,
3K, and pVIII) and the E3 mRNAs suggests that there is
common polyadenylation signal at nt 1729–1738 (Cau-
hen and Spindler, unpublished observations). Use of a
ommon polyadenylation signal would require some
verlap of the L4 mRNAs with the E3 mRNAs. pVIII PCR
roducts from RT-PCR of late viral mRNA are consistent
ith a common polyadenylation signal for pVIII and E3
Cauthen and Spindler, unpublished observations). The
VIII coding region also overlaps with and is translated
n the same frame as the N-terminus of the E3 proteins
Fig. 1). The pVIII coding region terminates within the first
ntron of the E3 region, giving rise to a protein predicted
o be 215 amino acids in length. We propose a model in
hich splicing of this first intron and the E3 gp11K-
pecific second intron from a pVIII mRNA would produce
n mRNA encoding a pVIII–gp11K fusion protein when eranslated (Fig. 1, lower portion). Evidence that supports
his model is that the 28K band immunoprecipitated from
n vitro translated RNA harvested from both wt- and
mE312-infected cells is the appropriate size for a pVIII–
p11K fusion. Also, while screening for E3 cDNAs from
n early (19–21 h p.i.) library, Beard et al. (1990) isolated
cDNA with a 59 end upstream of the E3 transcription
tart site that was spliced at the first E3 intron and the
p11K-specific second intron. To further confirm the ex-
stence of such an mRNA, we performed RT-PCR of late
nfected-cell mRNAs and cloned the resulting products.
otal RNA was isolated from mock-, wt-, and pmE312-
nfected cells at 40 h p.i. The RNA was reverse tran-
cribed using random hexamers and PCR amplified us-
ng a left-end primer (MAVR444) that is 19 nucleotides 39
f the start of the pVIII coding region and a right end
rimer (MAVR1445) that lies on the 39 side of the second
3 intron (Fig. 1). This primer set does not amplify E3
essages that are transcribed from the nearby early E3
romoter since the start site for early E3 transcription
as mapped to nt 793 and 796 (Beard et al., 1990). The
esulting PCR products were cloned, and inserts that
ere the predicted size for the PCR product of a pVIII–
p11K encoding cDNA were sequenced. Sequence anal-
sis revealed a PCR product from both wt- and pmE312-
nfected cells that was consistent with our prediction of
mRNA encoding a pVIII–gp11K fusion. These cloned
CR products had the structure depicted in the lower
ortion of Fig. 1, extending from nucleotides 444 to 1445
nd with splice junctions at nucleotides 932/1085 and
256/1414. These splice junctions are identical to the first
3 intron and the second intron that are specific for
p11K, respectively (Beard et al., 1990).
DISCUSSION
In cells infected with a MAV-1 initiator codon mutant,
mE312, gp11K was produced at late but not early times
n infection (Fig. 2). This result was shown by immuno-
recipitation of gp11K using two antisera that recognize
ifferent E3 epitopes. Like gp11K from wt-infected cells,
he gp11K synthesized in pmE312 infection was localized
o the ER, as determined by treatment of immunoprecipi-
ated gp11K protein with endo H. Although these results
ndicate that pmE312 was not null for the E3 protein
ynthesis as expected, important aspects of gp11K ex-
ression were revealed by subsequent experiments.
We considered the initiation of translation of gp11K
rom the mutated initiator codon(s) to be unlikely. In
mE312-infected cells, gp11K was not produced in the
resence of araC, a DNA synthesis inhibitor, indicating
hat the initiator codon mutation did eliminate translation
f mRNAs from the early promoter and that gp11K de-
ected at late times must have been synthesized from a
ate transcript (Fig. 3). AraC treatment would have no
ffect on gp11K synthesized from the early promoter,
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125LATE EXPRESSION OF MAV-1 gp11Khereas araC would prevent DNA replication-dependent
ate expression of gp11K. Accordingly wt-infected cells
ynthesized gp11K when treated with araC; gp11K is
nown to be translated from mRNAs transcribed from an
arly promoter (Beard et al., 1990).
We sought an explanation for how gp11K was pro-
uced at late times in pmE312-infected cells from a late
ranscript in the absence of initiator codons. Since the E3
egion is embedded in the late genes, we hypothesized
hat a fusion between a late protein and gp11K could
roduce the 14K band seen in the immunoprecipitations
n Figs. 2 and 3 by translocation of the fusion protein to
he ER, using the gp11K signal sequence. We detected
uch a fusion protein of 28K in in vitro translation reac-
ions of wt- and pmE312-infected cell RNAs (Fig. 4). This
esult indicated that the 28K band contained an epitope
n common with gp11K and that it was translated from a
ate transcript. The molecular weight of this 28K band is
onsistent with an unprocessed pVIII–gp11K fusion of
69 amino acids. Since the band was less intense upon
ddition of CPMM, it is likely that the protein was di-
ected to and translocated by the CPMM. We envision
hat the signal sequence of gp11K translocates the fu-
ion protein to the ER, and the signal sequence is
leaved at its normal site. This cleavage would produce
late protein fused to the gp11K signal sequence plus
he mature gp11K protein. Perara and Lingappa (1985)
nd Simon et al. (1987) showed that an N-terminal pro-
ein signal sequence could translocate a protein in X.
aevis oocytes or across CPMM when placed between
wo protein sequences. The size of the protein N-termi-
al to the signal sequence did not have an effect on the
fficiency of translocation of the C-terminal protein. In
hose studies the size of the signal sequence for the
ngineered proteins used was 30 amino acids with 110
r 200 amino acids engineered upstream. The signal
equence for the proposed MAV-1 pVIII–gp11K fusion
ould be 35 amino acids (from gp11K) with 169 amino
cids (from pVIII) upstream. We propose that the
-terminal 204-amino-acid pVIII signal sequence is effi-
iently cleaved, and the C-terminal 64-amino-acid gp11K
s translocated to the ER. In support of this finding, the
roduct we detected from pmE312-infected cells was the
ature gp11K size of 14K and localized to the ER (Fig. 2).
he translocation and processing of pVIII–gp11K are
ikely coupled with translation and would explain why the
69-amino-acid fusion protein was not detected in in-
ected cells.
The proposed pVIII–gp11K signal sequence product
enerated by the cleavage of the pVIII–gp11K fusion at
he normal gp11K signal sequence cleavage site could
ave several fates. First, and most likely, the pVIII signal
equence product could be quickly degraded (Simon et
l., 1987). Second, the product could be translocated to
he ER at low efficiency as seen by Perara and Lingappa
1985) and Simon et al. (1987) in studies involving CPMM pn in vitro translation reactions or in X. laevis oocytes.
ranslocation of the pVIII–gp11K signal sequence prod-
ct would produce a protein that either is mislocalized or
ould have a function in the ER. It is not known which of
hese hypotheses is correct, and the tools to study this
uestion are not available at present. The impact of a
VIII–gp11K chimeric protein on pVIII function or on the
ife cycle of the virus is unknown. We propose that the
mall percentage of pVIII made in the form of a fusion
rotein in both wt and mutant infections does not signif-
cantly reduce the levels of pVIII because pVIII is made in
reat excess during infection.
RT-PCR data summarized in the lower portion of Fig. 1
upport the hypothesis that pVIII is the late protein that is
used to gp11K to produce the 28K band observed in Fig.
. We isolated clones containing RT-PCR fragments from
oth wt- and pmE312-infected cell RNA that encode se-
uences consistent with a pVIII–gp11K fusion. Although
ther L4 mRNAs also overlap with E3, it is unlikely that
p11K translated from a late transcript results from either
100K– or a 33K–gp11K fusion. A fusion between 100K or
3K and gp11K would likely be larger than 28K when
ranslated as a fusion protein, as would a fusion of 100K
r 33K plus pVIII–gp11K. The coding regions of 100K and
3K terminate well upstream of the E3 region. If either
as fused to the E3 coding region, a more complex
plicing scheme would have to be used to generate a
ate protein–gp11K fusion. Immunoprecipitation of the
8K band with a pVIII-specific antiserum from wt- and
mE312-infected in vitro translated RNA would be the
ost direct method to show that our model is correct.
owever, we have not been able to produce such an
ntiserum. We have generated polyclonal antisera di-
ected against a pVIII synthetic peptide and a glutathione
-transferase–pVIII fusion protein, but neither was capa-
le of immunoprecipitating pVIII from either radiolabeled
nfected cell lysates or in vitro translated RNAs. Possible
xplanations for the failure to produce useful antisera
ould be the affinity or avidity of the pVIII antisera, the
oncentration of the specific antibodies in the antisera,
r the concentration or conformation of pVIII in cell ly-
ates or in vitro translation reactions. We cannot obtain
nough of the 28K band (Fig. 4) for a direct microse-
uence analysis. Although we cannot prove that the late
rotein fused to gp11K is pVIII, a pVIII–gp11K fusion is
he simplest model to explain the 28K fusion protein we
bserved. Both the fusion protein size (Fig. 4) and the
equence of RT-PCR clones (Fig. 1) are consistent with
his model.
The expression of E3 gp11K in the absence of an
nitiator codon is similar to results found for pmE310, an
TG 3 TTG E3 initiator methionine mutant (Beard and
pindler, 1996). However, the original conclusions drawn
rom the pmE310 experiments were different. In the study
f pmE310, gp11K was also immunoprecipitated from
mE310-infected cell lysates at late times and was sen-
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126 CAUTHEN AND SPINDLERitive to endo H, but it was hypothesized from those
esults that the gp11K produced by pmE310 was due to
eaky translation from the TTG codons in the initiator
ositions. However, the presence of E3 proteins was
ssayed only at late times after infection in the absence
f araC, so it was unknown whether pmE310 synthesized
p11K at early times or whether gp11K synthesis was
ependent on DNA replication. Subsequent experiments
ave shown that pmE310 does not synthesize gp11K at
arly times in infection (Cauthen and Spindler, unpub-
ished observations); thus it is likely that pmE310 gp11K
xpression is due to the mechanism described here
ather than leaky translation.
Experiments in mice showed that both pmE310 and
mE312 were less virulent (had higher LD50 values) than
t virus (Beard and Spindler, 1996; this work). However,
he LD50 value of pmE312 was approximately 1 log unit
igher than that of pmE310. Experiments in cultured
ouse fibroblasts showed that pmE312 synthesized less
p11K at late times in infection from a late transcript than
mE310. Another E3 mutant (pmE314) synthesized no
etectable gp11K at early or late times, and its LD50 value
as 3–4 log units higher than those of pmE312 and
mE310 (Cauthen and Spindler, unpublished results).
aken together, these results suggest that the amount of
p11K expressed was important for the pathogenicity of
he virus in mice, with the relative level of gp11K detected
n each mutant being proportional to the relative viru-
ence of that mutant. The biological relevance of synthe-
is of gp11K from a late transcript is also indicated by
ata in Fig. 4 showing that gp11K is synthesized from a
ate transcript in wt-infected cells. This indicates that the
esult seen with pmE312 is not an artifact of mutagene-
is. Further studies in cultured endothelial cells or mono-
ytes (natural targets of the virus in mice) may be useful
n studying regulation of MAV-1 E3 expression and may
e helpful in determining the exact role of MAV-1 E3
roducts by more closely mimicking the in vivo infection.
MATERIALS AND METHODS
Cells, viruses, and infections of mice. 3T6 cells were
aintained in Dulbecco’s modified Eagle’s medium
DMEM) supplemented with 5% heat-inactivated calf se-
um (HICS). IE3.3 cells were maintained in DMEM sup-
lemented with 8% HICS and 200 mg/ml G418. IE3.3 is a
ell line derived from 3T6 cells that were stably trans-
ected with pMOD, a plasmid that encodes the E3 pro-
eins under the control of a glucocorticoid responsive
nducible promoter from mouse mammary tumor virus.
MOD was constructed by insertion of an E3 fragment
nt 878–1950; numbering scheme is for the MAV-1
indIII-C fragment; Accession No. M30594 (Raviprakash
t al., 1989)] into pJ5V (Morgenstern and Land, 1990).
he IE3.3 cell line was established using the method
escribed for 37.1 cells (Smith et al., 1996). pmE101 is a (irus with a point mutation eliminating the EcoRI restric-
ion site in the E1 region (Beard and Spindler, 1996). Like
t virus, pmE101 has an EcoRI site in the first intron of
3, and it behaves as wt virus in all tests performed to
ate. pmE101 is referred to as wt virus throughout this
ork. pmE312 was constructed from pmE101 using the
ethod described previously (Beard and Spindler, 1996)
s follows. Oligonucleotide site-directed mutagenesis
Amersham) was used to introduce mutations into
MUT-1, a plasmid encoding the MAV-1 E3 region and
dentical to pMUT-2 (Smith et al., 1996, 1998). The MAV-1
equence of pMUT-1 is identical to that of wt virus with
he exception of a nucleotide change that eliminates the
coRI site in the first intron of the E3 region without
ltering the amino acid sequence of pVIII. To render the
3 region null for protein expression, the methionine
odons at positions 1 and 4 in the E3 protein sequence
hat are shared by all three of the E3 coding regions were
utated to leucines (TTAs) using the oligonucleotide
AVR876-TTA (59 CT CTT TCT G CA AGC TTA TCC GAA
TA AGC GGG GC 39, where boldface regions represent
hanges from wt virus sequence, and the underlined
egion represents a unique restriction site incorporated
o aid in screening for mutant viruses). The other two
ethionine codons in the E3 coding region were also
utated to leucines using MAVR1449 and MAVR1596
Beard and Spindler, 1996), yielding a plasmid, pMUT-
TA, with all four MAV-1 E3 methionine codons mutated
o leucine codons. pMUT-TTA was linearized and co-
ransfected with EcoRI-digested, partially filled-in
mE101 DNA–protein complex (Beard and Spindler,
996). Using the calcium phosphate precipitation method
Gorman et al., 1983), the DNAs were introduced into
E3.3 cells. Viable virus was obtained by homologous
ecombination between plasmid and viral DNA and was
solated as plaques on IE3.3 cells. Plaques were picked
nd screened by PCR followed by restriction digestion as
reviously described (Beard and Spindler, 1996). Three
ndependent isolates were obtained, and sequence anal-
sis (fmol DNA Sequencing System, Promega) revealed
hat each isolate contained all of the expected mutations.
ata for one of the three isolates, pmE312, are presented
ere.
LD50 determinations were done in male adult NIH
wiss outbred mice as described (Beard and Spindler,
996; Smith et al., 1998). LD50 values were calculated by
he method of Reed and Muench (1938).
Cell labeling and immunoprecipitation. 3T6 cells were
ock-, pmE101-, or pmE312-infected at an m.o.i. of 1
FU/cell. Virus was added to cells and allowed to adsorb
or 1 h at 37°C followed by addition of DMEM supple-
ented with 1% HICS. Cells were radiolabeled with 30
Ci/ml of [35S]cysteine (Amersham) for 4 h prior to har-
est, in medium lacking cysteine and containing 2% di-
lyzed newborn calf serum. In experiments where araCSigma) was used, it was added to the infected cells at
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127LATE EXPRESSION OF MAV-1 gp11Khe time of infection at 20 mg/ml and at 12-h intervals
ntil cells were harvested (Smith et al., 1996). Samples
ere harvested at 20 h p.i. (early time point) or 40 h p.i.
late time point) by scraping the cells into the medium
nd washing the cell pellet with cold PBS. The cell
ellets were resuspended in cold PBS and divided into
liquots containing 2 3 106 trichloroacetic acid-precipi-
able cpm. Cell pellets were resuspended in 350 ml of
ysis buffer (500 mM NaCl, 50 mM Tris–HCl (pH 7.4), 1%
P-40, 100 mg/ml aprotinin for immunoprecipitation of E3
nd virion proteins, or E1A lysis buffer for E1A protein as
escribed) (Smith et al., 1996). Samples were precleared
ith normal rabbit serum that had been purified using
EAE-Affigel-blue (Bio-Rad). E3 proteins were immuno-
recipitated with either a-E3-1 antiserum, which recog-
izes only epitopes in the unique portion of gp11K (Beard
nd Spindler, 1995), or a-Eall3 antiserum, which recog-
izes an epitope common to all three E3 proteins (Beard
nd Spindler, 1996). As controls for early and late viral
rotein expression from infected cells, E1A protein was
mmunoprecipitated with AKO 7-147 (Smith et al., 1996),
nd virion proteins were immunoprecipitated with an
-virion antiserum, AKO 1-68 (Kajon et al., 1998). Precip-
tates were collected using protein A–Sepharose (Phar-
acia) and washed twice with lysis buffer and once with
0 mM Tris–HCl, pH 6.8. The samples were then resus-
ended in sample buffer (0.0625 M Tris–HCl, pH 6.8, 2%
DS, 0.715 M b-mercaptoethanol, 10% glycerol, 0.001%
romophenol blue), boiled, and separated on a 10–18%
radient polyacrylamide SDS gel (Laemmli, 1970). Pro-
eins were visualized with a phosphorimager (Molecular
ynamics). Endoglycosidase H (New England Biolabs)
igestions were as previously described (Beard and
pindler, 1995).
RNA isolation and in vitro translation of a late E3
ranscript. Total RNA was isolated from mock-, pmE101-,
nd pmE312-infected cells (m.o.i. 5 0.5) as previously
escribed (Ball et al., 1989). Poly(A)1 RNA was isolated
rom total RNA samples using the PolyATract mRNA
solation System IV (Promega). Poly(A)1 RNA (0.5–1 mg)
as translated in vitro using the Nuclease Treated Rab-
it Reticulocyte Lysate System (Promega) according to
he manufacturer’s directions. Where noted, 7.2 equiva-
ents of CPMM (Promega) was added to in vitro transla-
ion reactions to allow signal sequence cleavage and
-linked glycosylation of proteins that enter the secre-
ory pathway. The in vitro translated proteins were then
mmunoprecipitated with a-E3-1 antiserum, electropho-
esed on a 10–18% gradient polyacrylamide SDS gel, and
isualized with a phosphorimager as described above.
RT-PCR, cloning, and sequencing of a late E3 tran-
cript. Ten micrograms of total RNA isolated from mock-,
mE101-, and pmE312-infected cells was treated with 5 U
f RNase-free RQ1 DNase (Promega) and incubated at
7°C for 30 min to remove contaminating DNA. The
amples were then phenol extracted, chloroform ex-racted, and ethanol precipitated. The RNA pellet was
esuspended in RNase-free water and denatured at
5°C for 10 min. The following was then added to each
ample in a final volume of 50 ml: 16 U AMV reverse
ranscriptase (Promega), AMV reverse transcriptase
uffer (50 mM Tris–HCl (pH 8.3), 50 mM KCl, 10 mM
gCl2, 0.5 mM spermidine, 10 mM dithiothreitol), 1 mM
eoxynucleoside triphosphates (dNTPs) (Pharmacia), 80
RNasin (Promega), and 40 pmol of random hexamers
Boehringer Mannheim). The reaction was incubated at
oom temperature for 15 min to promote annealing of
rimers, followed by reverse transcription at 42°C for 90
in. The AMV reverse transcriptase was inactivated by
ncubation at 94°C for 10 min. Two microliters of each
everse-transcribed DNA was amplified by PCR in a
eaction volume of 25 ml containing 50 mM KCl, 10 mM
ris–HCl (pH 9.0), 0.1% Triton X-100, 0.5 mM MgCl2, 1 U of
aq polymerase (Promega), 0.2 mM dNTPs, and 250 ng
ach of MAVR444 (59 ATG TGT GGA CTT TTC AGC CTC
GC GGG GTA 39) and MAVR1445 (59 TTG AGG ACT CAG
AG GTA CAG GGC AAT ACT 39). The PCR amplification
as carried out for 29 cycles at an annealing tempera-
ure of 65°C. After the reactions were complete, the
emaining PCR primers were removed using the Wizard
NA Clean-Up System (Promega), and the PCR products
ere cloned using the Invitrogen One Shot Kit. Clones
ontaining an insert of the proper size were sequenced
sing both MAVR1098 (59 TGT GCC TGC TTC TAC TC 39)
nd MAVR1180 (59 CTG ACA CTG CGA TGG TTG 39) and
isualized by autoradiography.
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